Longitudinal hysteroscopic follow-up during tamoxifen treatment

Lancet. 1998 Jan 3;351(9095):36. doi: 10.1016/s0140-6736(05)78091-0.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents, Hormonal / adverse effects*
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Breast Neoplasms / drug therapy
  • Cohort Studies
  • Endometrial Hyperplasia / chemically induced
  • Endometrial Hyperplasia / epidemiology
  • Endometrial Neoplasms / chemically induced*
  • Endometrial Neoplasms / epidemiology
  • Female
  • Follow-Up Studies
  • Humans
  • Hysteroscopy
  • Postmenopause
  • Risk Factors
  • Tamoxifen / adverse effects*
  • Tamoxifen / therapeutic use
  • Time Factors

Substances

  • Antineoplastic Agents, Hormonal
  • Tamoxifen